Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Exercise/Conversion of 54,174 PTGX shares, $1.17M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 54,174 | $1.17M |
| Sep 8, 2026 | Protagonist Therapeutics, Inc (PTGX) | Gift | 510 | n/a |
| Aug 12, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 65,761 | $1.42M |
| May 15, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 75,000 | $1.62M |
| Apr 24, 2026 | Protagonist Therapeutics, Inc (PTGX) | Gift | 1,460 | n/a |
| Mar 25, 2026 | Protagonist Therapeutics, Inc (PTGX) | Gift | 50,000 | n/a |
| Jan 28, 2026 | Protagonist Therapeutics, Inc (PTGX) | Gift | 6,000 | n/a |
| Jan 21, 2026 | Protagonist Therapeutics, Inc (PTGX) | Sale | 34,438 | $2.84M |
| Jan 7, 2026 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 95,400 | n/a |
| Nov 24, 2025 | Protagonist Therapeutics, Inc (PTGX) | Gift | 440 | n/a |